Case Studies
Obtaining Regulatory Approval for a First-of-Its-Kind Insurance Product

Case Study — Insurance Regulation & P&C Product Approval
The product was a property and casualty insurance policy designed to protect homeowners against negative equity, the risk that a home's market value has fallen below the outstanding mortgage balance. No admitted P&C product had covered that exposure before.
Critically, the policy did not pay a cash benefit to the insured. It operated as a coordination and shortfall-coverage mechanism. When an insured wished to sell a home and had, or believed it had, negative equity, the insurer coordinated the marketing, sale, and closing of the transaction through its network of settlement service providers. If the net sale proceeds fell short of the amount needed to pay off the insured mortgage, the realtor commissions, and the closing costs, the insurer covered that shortfall directly. The insured incurred no out-of-pocket expense to sell the home. The benefit ran to the transaction, discharging the payoff and transaction costs, not as a sum handed to the policyholder measured by a decline in value.
This distinction mattered, because this type of coverage was seemingly similar to coverage that P&C insurers are not permitted to write.
While serving as an insurance executive, Mark’s role was to obtain admission of the product as an approved P&C offering across multiple states. That meant preparing and prosecuting form and rate filings jurisdiction by jurisdiction, including drafting the policy form and endorsements, coordinating the actuarial and underwriting support, and responding to each department's objections through the filing process. In most states the filings moved through review and were approved on the strength of the form language and rate justification.
One state did not.
A prominent state insurance regulator reviewed the filing and took the position that the product was not P&C insurance at all, but financial guaranty insurance — a restricted monoline line that a general P&C insurer is not authorized to write. The objection, if sustained, would have barred the product from the state entirely.
The regulator's reasoning followed the statutory definition. Financial guaranty insurance is coverage under which loss is payable, upon proof of financial loss, as a result of changes in the value of specific assets or price levels in general. A product responding when a home is worth less than its mortgage, the regulator reasoned, looked like insurance against a decline in asset value — squarely within that definition, and therefore off-limits to the insurer.
Mark engaged the department directly rather than through paper objections alone. The response proceeded on two tracks: written submissions setting out the legal basis for classifying the product as P&C, and a series of meetings with the department's property/casualty and legal staff to work through the classification question in detail.
The substantive argument was that the product's mechanics did not match the financial-guaranty definition, which is keyed to a payment made on proof of financial loss resulting from a change in asset value or price levels. Two features took the product outside that definition:
Mark reinforced the point with the structure of the statute itself, which distinguishes bare value-change guaranties from event-triggered indemnity coverage and carves the latter out of the financial-guaranty line. The negative-equity product sat on the indemnity side of that line: coverage was triggered by the insured's decision to sell and the occurrence of a shortfall on an actual closing, and the insurer's performance was the coordination of that sale and the payment of real costs — not a promise to make a counterparty whole against a market decline.
Working with the department's staff, Mark addressed each concern on the record and, where useful, refined policy language to make the coordination-and-shortfall mechanics unambiguous — reinforcing that the insurer coordinated the sale and covered defined transaction costs, and that no value-indexed sum was ever paid to the insured.
The regulator accepted the classification and approved the product for sale in the state. The department concluded that the coverage was permissible P&C insurance rather than financial guaranty insurance, allowing the product to be sold there alongside the states where it had already been admitted.
The matter illustrates a recurring dynamic in novel-product approval: a first-of-its-kind coverage will often be tested against the boundary of a restricted line, and the outcome turns less on the product's economic subject matter than on how its trigger and payment mechanics are structured and substantiated. Showing that the product coordinated a sale and covered actual transaction costs in kind — rather than paying the insured a value-indexed benefit — is what kept it inside the P&C system.
This case study is provided for general informational purposes only and is based on an anonymized matter; identifying details of the parties, regulator, and jurisdiction have been omitted or altered to preserve confidentiality. It does not constitute legal advice. Classification outcomes depend on the specific product design and the governing insurance law of each state. Prior results do not guarantee a similar outcome.